Eye tracking technology leader SensoMotoric Instruments (SMI) from Germany today reveals an impressive piece of technology for user experience studies and gaze interaction applications in virtual environments.
Leading innovator in virtual reality SensoMotoric Instruments (SMI) has today unveiled a modified Samsung Gear VR that makes mobile VR with eye tracking commercially available for the first time.
"SMI's release has the potential to significantly advance our research on gaze-based assistance systems. We expect a more precise differentiation of viewing time as 120Hz promises a better temporal fit and low latency synchronization with our motion ...
SensoMotoric Instruments (SMI) is partnering with Lufthansa Systems to combine its renowned eye tracking with the NetLine/Ops ++ airline operations control solution.
The Organizers of Open Source Virtual Reality (OSVR) today announce a new software plug-in that supports eye tracking technology by SensoMotoric Instruments (SMI). The OSVR eye tracking interface brings vendor-agnostic real-time eye and gaze data to ...
Psychology Software Tools (PST) and SensoMotoric Instruments (SMI) present a deep integration of their established technologies for psychology and neuroscience research.
Today, High Fidelity, Inc. and SensoMotoric Instruments (SMI) announce the integration of SMI HMD Eye Tracking technology with the High Fidelity social VR platform.
At the 2015 Siggraph Conference, SensoMotoric Instruments (SMI) shows the world's first Eye Tracking Integration for augmented reality, based on Epson's Moverio BT-200 see-through head mounted display and on SMI's mobile eye tracking platform.
14, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that CEO Linda Powers will present at the SMi ...
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.